Artal S.A. 13F annual report

Artal S.A. is an investment fund managing more than $3.89 trillion ran by Anne Goffard. There are currently 109 companies in Mrs. Goffard’s portfolio. The largest investments include Cava Group Inc and Lexicon Pharmaceuticals Inc, together worth $2.47 trillion.

Limited to 30 biggest holdings

$3.89 trillion Assets Under Management (AUM)

As of 7th August 2024, Artal S.A.’s top holding is 23,507,990 shares of Cava Group Inc currently worth over $2.18 trillion and making up 56.0% of the portfolio value. In addition, the fund holds 175,099,384 shares of Lexicon Pharmaceuticals Inc worth $294 billion, whose value fell 47.9% in the past six months. The third-largest holding is Scholar Rock Corp worth $93.8 billion and the next is Kymera Therapeutics worth $89.7 billion, with 3,005,610 shares owned.

Currently, Artal S.A.'s portfolio is worth at least $3.89 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Artal S.A.

The Artal S.A. office and employees reside in Luxembourg, Luxembourg. According to the last 13-F report filed with the SEC, Anne Goffard serves as the Authorized Person at Artal S.A..

Recent trades

In the most recent 13F filing, Artal S.A. revealed that it had opened a new position in Avidity Biosciences and bought 655,555 shares worth $26.8 billion. This means they effectively own approximately 0.1% of the company. Avidity Biosciences makes up 2.0% of the fund's Health Care sector allocation and has grown its share price by 419.7% in the past year.

The investment fund also strengthened its position in Lexicon Pharmaceuticals Inc by buying 57,546,100 additional shares. This makes their stake in Lexicon Pharmaceuticals Inc total 175,099,384 shares worth $294 billion. Lexicon Pharmaceuticals Inc soared 1.8% in the past year.

On the other hand, there are companies that Artal S.A. is getting rid of from its portfolio. Artal S.A. closed its position in Madrigal Pharmaceuticals Inc on 14th August 2024. It sold the previously owned 110,507 shares for $29.5 billion. Anne Goffard also disclosed a decreased stake in Cava Group Inc by 0.1%. This leaves the value of the investment at $2.18 trillion and 23,507,990 shares.

One of the largest hedge funds

The two most similar investment funds to Artal S.A. are Parallel Advisors and Turtle Creek Asset Management Inc. They manage $3.9 trillion and $3.88 trillion respectively.


Anne Goffard investment strategy

Artal S.A.’s portfolio is diversified across 7 sectors. Currently, their heaviest sector is Health Care — making up 34.3% of the total portfolio value. The fund focuses on investments in the United States as 55.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 21% of the total holdings value. On the other hand, small-cap stocks make up only 5.5% of the portfolio. The average market cap of the portfolio companies is close to $87.3 billion.

The complete list of Artal S.A. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Cava Group Inc
11.32%
23,507,990
$2,180,366,073,000 55.98%
Lexicon Pharmaceuticals Inc
48.95%
175,099,384
$294,166,966,000 7.55%
Scholar Rock Holding Corp
No change
11,259,438
$93,791,119,000 2.41%
Kymera Therapeutics, Inc.
0.71%
3,005,610
$89,717,459,000 2.30%
Morphic Holding Inc
14.13%
2,525,998
$86,060,752,000 2.21%
Arrowhead Pharmaceuticals Inc.
5.03%
3,189,389
$82,892,220,000 2.13%
Apellis Pharmaceuticals Inc
11.54%
1,467,080
$56,277,189,000 1.44%
Dyne Therapeutics, Inc.
0.07%
1,516,960
$53,533,518,000 1.37%
Silence Therapeutics plc
No change
2,779,619
$52,812,761,000 1.36%
SpringWorks Therapeutics, Inc.
7.23%
1,313,026
$49,461,689,000 1.27%
Crinetics Pharmaceuticals Inc
23.33%
1,066,064
$47,749,007,000 1.23%
Merus Nv
67.08%
760,355
$44,990,205,000 1.16%
BeiGene Ltd
25.05%
303,369
$43,281,655,000 1.11%
Revolution Medicines Inc
22.97%
1,015,776
$39,422,267,000 1.01%
Kura Oncology Inc
5.21%
1,819,884
$37,471,412,000 0.96%
Vera Therapeutics Inc
81.02%
915,974
$33,139,939,000 0.85%
Madrigal Pharmaceuticals Inc
Closed
110,507
$29,509,789,000
Neumora Therapeutics Inc
3.42%
2,824,052
$27,760,431,000 0.71%
Cytokinetics Inc
2.40%
494,421
$26,787,730,000 0.69%
Avidity Biosciences, Inc.
Opened
655,555
$26,779,422,000 0.69%
IGM Biosciences, Inc.
8.12%
3,330,422
$22,879,999,000 0.59%
Wave Life Sciences Ltd.
12.71%
4,566,251
$22,785,592,000 0.59%
Erasca Inc
103.99%
9,630,810
$22,728,712,000 0.58%
Tango Therapeutics Inc
14.81%
2,519,841
$21,620,236,000 0.56%
Viking Therapeutics Inc
Closed
253,863
$20,816,766,000
Prothena Corporation plc
No change
1,001,360
$20,668,070,000 0.53%
Centessa Pharmaceuticals Plc
49.56%
2,112,500
$19,075,875,000 0.49%
Cullinan Therapeutics Inc
Opened
1,057,949
$18,450,631,000 0.47%
Alpine Immune Sciences Inc
Closed
405,784
$16,085,278,000
Newamsterdam Pharma Company Nv
No change
800,000
$15,368,000,000 0.39%
Xenon Pharmaceuticals Inc
50.58%
381,554
$14,876,790,000 0.38%
Edgewise Therapeutics Inc
No change
811,718
$14,619,041,000 0.38%
Solid Biosciences Inc
No change
2,500,000
$14,175,000,000 0.36%
Korro Bio Inc
1.47%
413,072
$13,990,749,000 0.36%
Ascendis Pharma A/S
Opened
101,100
$13,788,018,000 0.35%
Agenus Inc
Opened
775,000
$12,981,250,000 0.33%
Syros Pharmaceuticals Inc.
No change
2,505,013
$12,925,867,000 0.33%
Astria Therapeutics Inc
Closed
884,214
$12,445,312,000
Gossamer Bio, Inc.
No change
13,308,968
$11,990,049,000 0.31%
Amicus Therapeutics Inc
Closed
1,011,776
$11,918,721,000
Denali Therapeutics Inc
No change
502,899
$11,677,315,000 0.30%
Ultragenyx Pharmaceutical Inc.
54.55%
275,000
$11,302,500,000 0.29%
Biohaven Ltd
Opened
306,703
$10,645,661,000 0.27%
Celldex Therapeutics Inc.
Closed
253,000
$10,618,410,000
Apogee Therapeutics Inc
Closed
152,500
$10,133,625,000
Taysha Gene Therapies, Inc.
18.08%
4,354,214
$9,753,439,000 0.25%
Lexeo Therapeutics Inc
24.73%
603,435
$9,679,097,000 0.25%
Agenus Inc
Closed
15,631,235
$9,066,116,000
Acelyrin Inc
15.98%
2,020,888
$8,912,116,000 0.23%
Janux Therapeutics Inc
306.00%
203,000
$8,503,670,000 0.22%
Cartesian Therapeutics Inc
Opened
304,554
$8,226,004,000 0.21%
Rapport Therapeutics Inc
Opened
350,000
$8,141,000,000 0.21%
Iovance Biotherapeutics Inc
Opened
1,011,500
$8,112,230,000 0.21%
Generation Bio Co.
No change
2,830,591
$7,982,267,000 0.20%
Seer, Inc.
No change
4,750,000
$7,980,000,000 0.20%
Vigil Neuroscience Inc
0.97%
1,828,691
$7,314,764,000 0.19%
Mind Medicine Mindmed Inc
Opened
1,007,875
$7,266,779,000 0.19%
Sea Ltd
58.95%
97,500
$6,963,450,000 0.18%
Structure Therapeutics Inc
Closed
151,780
$6,505,291,000
Axsome Therapeutics Inc
Closed
76,837
$6,131,593,000
PDD Holdings Inc
19.47%
45,500
$6,049,225,000 0.16%
Cartesian Therapeutics Inc
Closed
9,136,635
$5,938,813,000
NVIDIA Corp
2,163.16%
43,000
$5,312,220,000 0.14%
Microsoft Corporation
352.00%
11,300
$5,050,535,000 0.13%
Visa Inc
660.00%
19,000
$4,986,930,000 0.13%
Black Diamond Therapeutics Inc
No change
1,046,517
$4,876,769,000 0.13%
Dynatrace Inc
202.78%
109,000
$4,876,660,000 0.13%
AlloVir, Inc.
No change
6,597,167
$4,771,731,000 0.12%
Applied Therapeutics, Inc.
No change
1,009,500
$4,714,365,000 0.12%
Taiwan Semiconductor Manufacturing Co Ltd
18.75%
26,000
$4,519,060,000 0.12%
Geron Corp.
Closed
1,281,194
$4,227,940,000
Foghorn Therapeutics Inc.
No change
720,720
$4,144,140,000 0.11%
Stoke Therapeutics Inc
Closed
300,000
$4,050,000,000
Datadog Inc
201.30%
28,925
$3,751,283,000 0.10%
Alto Neuroscience Inc
No change
350,000
$3,741,500,000 0.10%
Amazon.com Inc.
60.42%
19,250
$3,720,063,000 0.10%
Fate Therapeutics Inc
186.56%
1,032,500
$3,386,600,000 0.09%
Hookipa Pharma Inc
No change
5,666,410
$3,353,381,000 0.09%
Repare Therapeutics Inc.
Closed
700,000
$3,297,000,000
ADC Therapeutics SA
Opened
1,018,461
$3,218,337,000 0.08%
KE Holdings Inc.
18.18%
225,000
$3,183,750,000 0.08%
Regenxbio Inc
No change
250,000
$2,925,000,000 0.08%
Adagene Inc
Closed
1,020,000
$2,856,000,000
Omega Therapeutics Inc
No change
1,323,530
$2,739,707,000 0.07%
Elevation Oncology Inc
33.05%
1,013,015
$2,735,141,000 0.07%
Kenvue Inc
Opened
137,000
$2,490,660,000 0.06%
Sagimet Biosciences Inc
No change
724,771
$2,478,717,000 0.06%
GlycoMimetics Inc
No change
8,589,064
$2,418,680,000 0.06%
Vor Biopharma Inc
Closed
1,000,000
$2,370,000,000
Procore Technologies, Inc.
240.00%
32,300
$2,141,813,000 0.05%
ServiceNow Inc
Opened
2,500
$1,966,675,000 0.05%
Ovid Therapeutics Inc
No change
2,500,000
$1,923,000,000 0.05%
Gritstone Bio Inc
194.00%
3,030,952
$1,872,825,000 0.05%
Pepgen Inc
43.34%
113,317
$1,808,539,000 0.05%
Apple Inc
Closed
10,000
$1,714,800,000
Palo Alto Networks Inc
50.00%
4,500
$1,525,545,000 0.04%
Kyverna Therapeutics Inc
No change
200,000
$1,500,000,000 0.04%
Qualcomm, Inc.
Opened
7,500
$1,493,850,000 0.04%
Aerovate Therapeutics Inc
Opened
809,600
$1,343,936,000 0.03%
Alphabet Inc
No change
7,000
$1,275,050,000 0.03%
Metagenomi Inc
No change
300,000
$1,224,000,000 0.03%
Tourmaline Bio Inc
70.93%
91,426
$1,175,738,000 0.03%
Rubrik Inc
Opened
35,000
$1,073,100,000 0.03%
Kronos Bio, Inc.
No change
842,954
$1,045,263,000 0.03%
MongoDB Inc
101.05%
4,021
$1,005,089,000 0.03%
New Oriental Education & Technology Group Inc.
16.67%
12,500
$971,625,000 0.02%
Kanzhun Ltd
Opened
50,000
$940,500,000 0.02%
JFrog Ltd
Opened
25,000
$938,750,000 0.02%
PayPal Holdings Inc
50.00%
15,000
$870,450,000 0.02%
Advanced Micro Devices Inc.
Closed
4,500
$812,205,000
Intel Corp.
Opened
25,000
$774,250,000 0.02%
Ironwood Pharmaceuticals Inc
No change
110,532
$720,669,000 0.02%
Pegasystems Inc.
No change
11,500
$696,095,000 0.02%
Snowflake Inc.
22.29%
5,051
$682,340,000 0.02%
Achilles Therapeutics Plc
No change
755,375
$615,631,000 0.02%
Confluent Inc
No change
19,000
$561,070,000 0.01%
Ccc Intelligent Solutions Holdings Inc
Opened
50,000
$555,500,000 0.01%
Meta Platforms Inc
Opened
1,100
$554,642,000 0.01%
Adobe Inc
70.97%
900
$499,986,000 0.01%
Intapp Inc
55.93%
13,000
$476,710,000 0.01%
Clearwater Analytics Hldgs I
Closed
25,000
$442,250,000
Hippo Hldgs Inc
Closed
24,000
$438,480,000
Tesla Inc
No change
2,000
$395,760,000 0.01%
Remitly Global Inc
Opened
25,000
$303,000,000 0.01%
Cyclerion Therapeutics, Inc.
15.34%
117,643
$270,579,000 0.01%
Caribou Biosciences Inc
No change
105,347
$172,769,000 0.00%
Dell Technologies Inc
Opened
1,000
$137,910,000 0.00%
Dlocal Ltd
65.06%
10,482
$84,799,000 0.00%
Perception Capital Corp Iii
Opened
126,666
$3,547,000 0.00%
Mink Therapeutics Inc
Closed
1,916
$1,740,000
No transactions found
Showing first 500 out of 130 holdings